Quantcast

Latest Low-density lipoprotein Stories

2014-02-04 08:33:16

Urges Reinstatement of SPA for Heart Drug Vascepa NEW YORK, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) asserts that the FDA did not live up to its own scientific integrity standards in rescinding the Special Protocol Assessment (SPA) related to the "ANCHOR" sNDA for the triglyceride (TG) lowering drug, Vascepa, and urges that the Agency adhere to its own policies in the appeal of the SPA rescission decision. (Photo:...

2014-02-03 23:24:59

Save 10% on all heart health lab testing in February. Use promo code HEART10 when ordering to save. Brecksville, OH (PRWEB) February 03, 2014 With Valentine's Day around the corner, Request A Test, a leading national provider of direct to consumer lab testing, wants to remind everyone to take care of their heart. During the month of February, all testing orders from the heart health category will be 10% off. To take advantage of this savings, customers just need to use promo code...

2014-02-03 23:03:44

Lab testing company offers discount on test panels on Feb. 7. Alpharetta, GA (PRWEB) February 03, 2014 The Centers for Disease Control estimates that heart disease is responsible for one in every four deaths annually in the United States. This February, to celebrate American Heart Health Month, ANY LAB TEST NOW® is encouraging Americans to Take Control Of Your Health® and come in for testing and monitoring. To further encourage Americans to get their heart health checked, ANY...

2014-01-30 16:26:43

RUTHERFORD-2 Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 RUTHERFORD-2 (RedUction of LDL-C with PCSK9 InhibiTion in HEteRozygous Familial HyperchOlesteRolemia Disorder Study-2) trial evaluating evolocumab in combination with statins and other lipid-lowering therapies in patients with heterozygous familial hypercholesterolemia (HeFH) met its co-primary...

2014-01-29 12:27:52

WOODBRIDGE, ON, Jan. 29, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies, announced that it received a Notice of Allowance for U.S. Application Serial Number US2012/025014 from the United States Patent and Trademark Office (USPTO). The patent titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD)...

2014-01-28 16:26:04

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) trial evaluating evolocumab in combination with statin therapy in patients with high cholesterol met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week...

2014-01-23 08:31:51

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 GAUSS-2 (Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-2) trial evaluating evolocumab in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 12 and the...

2014-01-22 10:31:44

Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn School of Medicine at Mount Sinai...

2014-01-22 08:29:20

Sterol/Stanol Softgels Offer a Convenient Way to Improve Cholesterol Levels NORTHRIDGE, Calif., Jan. 22, 2014 /PRNewswire/ -- A research study published this month in the Journal of the Academy of Nutrition and Dietetics demonstrates the effectiveness of a sterol/stanol ester softgel capsule for lowering low-density lipoprotein (LDL) cholesterol in individuals with high cholesterol levels. Plant sterols and stanols occur naturally in plant-based foods and have been shown to decrease...

2014-01-20 23:03:55

Icahn School of Medicine at Mount Sinai Designs HDL Nanoparticle to Deliver Statin Medication Inside Inflamed Blood Vessels to Prevent Repeat Heart Attacks and Stroke New York, NY (PRWEB) January 20, 2014 Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related